April 23: Letters of Intent Due
The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute® (HDI) have partnered to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. The ADDF Harrington Scholar Award provides dedicated support from a project management team and pharmaceutical industry experts, as well as funding of up to $600,000 for 2 years.
| UNC-CH